Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements (Q37505185)
scientific article published on 12 January 2012
Language:
(P31) (Q13442814)
(P50) (Q42678349)
(Q57693292)
(Q47354038)
(Q38641744)
(Q130662933)
(P304) 2056-2065
(P407) (Q1860)
(P433) 7
(P478) 18
(P577) Thursday, January 12, 2012
(P921) (Q7448840)
(Q1152227)
(Q2292945)
(P1433) (Q332253)
(P1476) "Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements" (language: en)
(P2093) Amy S Lucas
Tawee Tanvetyanon
Barbara A Murphy
Jill Gilbert
Ranee Mehra
Dominic T Moore
Arif Sheikh
Janelle Hoskins
Michele C Hayward
Ni Zhao
Wendi O'Connor
Roger B Cohen
(P2860) (Q27860458)
(Q37628741)
(Q34608416)
(Q29547625)
(Q28289851)
(Q34791480)
(Q36877022)
(Q37121708)
(Q27851426)
(Q36732681)
(Q35988122)
(Q33995708)
(Q35189440)
(Q27860760)
(Q27860904)
(Q40079043)
(Q40093939)
(Q40164535)
(Q40301455)
(Q54323561)
(Q54420344)
(Q45346373)
(Q50778135)
(Q46912384)
(Q46200580)
(Q53576256)
(Q46650502)
(Q44595824)
(Q44387406)
(Q44003955)
(Q57762250)
(Q68488671)
(Q60527142)
(Q72991392)
(Q60559931)
(Q82293286)
(Q62581238)
(Q73276150)
(Q58813394)
(Q81248210)
other details
description scientific article published on 12 January 2012

External Links